| BCBS Federal Medical & Drug | 2.04.149 Molecular Testing for Germline Variants Associated with Ovarian Cancer (BRIP1, RAD51C, RAD51D, NBN) | 2025-12-01 |
| BCBS Federal Medical & Drug | 2.04.153 Tumor Informed Circulating Tumor DNA Testing for Cancer Management | 2025-12-01 |
| BCBS Federal Medical & Drug | 2.04.154 Germline Genetic Testing for Hereditary Diffuse Gastric Cancer (CDH1, CTNNA1) | 2025-12-01 |
| BCBS Federal Medical & Drug | 2.04.159 Laboratory Testing Investigational Services | 2025-12-01 |
| BCBS Federal Medical & Drug | 3.03.02 Digital Health Technologies: Therapeutic Applications | 2025-12-01 |
| BCBS Federal Medical & Drug | 3.03.03 Digital Health Therapies for Attention Deficit/Hyperactivity Disorder | 2025-12-01 |
| BCBS Federal Medical & Drug | 6.01.01 Bone Mineral Density Studies | 2025-12-01 |
| BCBS Federal Medical & Drug | 6.01.03 Computed Tomography to Detect Coronary Artery Calcification | 2025-12-01 |
| BCBS Federal Medical & Drug | 6.01.06 Miscellaneous (Noncardiac, Nononcologic) Applications of Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography | 2025-12-01 |
| BCBS Federal Medical & Drug | 6.01.10 Stereotactic Radiosurgery and Stereotactic Body Radiotherapy | 2025-12-01 |